Navigation Links
Boston Scientific Announces Positive Data From Lotus™ Transcatheter Aortic Valve Trial
Date:5/15/2012

E Mark and other international regulatory approvals.  Enrollment is expected to be completed in the first half of 2013. 

The Lotus Aortic Valve System™ is an investigational device, limited by applicable law to investigational use and not available for sale.  The device was developed by Sadra Medical, which Boston Scientific acquired in 2011.  For more information, visit www.sadramedical.com.About Aortic Valve Disease
Aortic valve disease results in dysfunction of the aortic valve, one of the four valves that control the flow of blood in and out of the heart.  Aortic valve stenosis is the process of thickening and stiffening in the valve, which can result in an abnormal narrowing of the aortic valve opening and reduction in blood flow.  Aortic stenosis is a common problem affecting approximately 3 percent of the population over age 65 and 5 percent of people older than 75.  From the onset of aortic stenosis symptoms, the average survival rate is 50 percent at two years and 20 percent at five years. 

About Boston Scientific
Boston Scientific is a worldwide developer, manufacturer and marketer of medical devices that are used in a broad range of interventional medical specialties.  For more information, please visit: www.bostonscientific.com. Cautionary Statement Regarding Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934.  Forward-looking statements may be identified by words like "anticipate," "expect," "project," "believe," "plan," "estimate," "intend" and similar words.  These forward-looking statements are based on our beliefs, assumptions and estimates using information available to us at the time and are not intended to be gua
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Boston Scientific and Philips Healthcare Announce Collaboration to Enhance Imaging Equipment Offering
2. Boston Scientific Announces CE Mark and European Launch of Emerge™ PTCA Dilatation Catheter
3. Medical Device Developers - Network at BIOMEDevice Boston Next Week
4. Boston to Host 3 Major Annual Drug Discovery Conferences, Early Bird Expiring April 27
5. Boston Scientific Launches Innovative Device Used to Prevent Stone Migration in Urologic Procedures
6. Annual Biotech and Healthcare Conferences Being Held in Boston MA, Summer 2012
7. Boston Scientific Announces Launch of PROMUS Element™ Platinum Chromium Stent System in Japan
8. Cadence Pharmaceuticals CEO Ted Schroeder to Present at the Cowen and Company 32nd Annual Health Care Conference in Boston on March 7, 2012
9. Boston Scientific Announces First Implants of TELIGEN® Implantable Defibrillator in China
10. Boston Scientific Receives Industrys First FDA Approval for Drug-Eluting Coronary Stent Use in Heart Attack Patients
11. Boston Scientific Launches Innovative Crossing Device to Treat Complete Blockages in Peripheral Arteries
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... Calif. , May 28, 2015  Based ... market, Frost & Sullivan recognizes Lexmark Healthcare ... Sullivan Award for Company of the Year in ... take HCM to the next level of interoperability ... acquisitions and followed them up with large-scale product ...
(Date:5/28/2015)... , May 28, 2015  Cardinal Health today ... acquire Johnson & Johnson,s Cordis business for $1.944 billion ... after consultations with relevant works councils and trade unions. ... the United States and key non-U.S. countries ... and other customary closing conditions. Headquartered in ...
(Date:5/28/2015)... 2015  Trovagene, Inc., (NASDAQ: TROV ) ... the launch of its "Yellow Is The New ... SM (PCM) service at the American Society ... center on Trovagene,s Clinical Experience Program, in which ... with the Company,s proprietary urinary liquid biopsy tests. ...
Breaking Medicine Technology:Frost & Sullivan Acknowledges Lexmark Healthcare's Energy, Creativity, and Diligence in Developing the Leading Next-Generation Healthcare Content Management Platform 2Frost & Sullivan Acknowledges Lexmark Healthcare's Energy, Creativity, and Diligence in Developing the Leading Next-Generation Healthcare Content Management Platform 3Frost & Sullivan Acknowledges Lexmark Healthcare's Energy, Creativity, and Diligence in Developing the Leading Next-Generation Healthcare Content Management Platform 4Frost & Sullivan Acknowledges Lexmark Healthcare's Energy, Creativity, and Diligence in Developing the Leading Next-Generation Healthcare Content Management Platform 5Cardinal Health Binding Offer To Acquire Cordis Accepted 2Cardinal Health Binding Offer To Acquire Cordis Accepted 3Cardinal Health Binding Offer To Acquire Cordis Accepted 4Trovagene Launches Commercial Marketing Campaign at the 2015 American Society of Clinical Oncology Annual Meeting 2Trovagene Launches Commercial Marketing Campaign at the 2015 American Society of Clinical Oncology Annual Meeting 3Trovagene Launches Commercial Marketing Campaign at the 2015 American Society of Clinical Oncology Annual Meeting 4
... NEW YORK, March 15, 2012 Reportlinker.com ... is available in its catalogue: ... http://www.reportlinker.com/p0578259/Vaccines---Asia.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This market ... on the actual market situation, trends and ...
... that closes a hole in patients, hearts is no more ... a new study published in the March 15 issue of ... the CLOSURE I trial, clinical researchers compared a catheter procedure ... or transient ischemic attacks (TIAs) in patients between 18 and ...
Cached Medicine Technology:Vaccines - Asia 2Landmark Study Finds Expensive Catheter Procedure to Close Hole in Heart No More Effective Than Medical Therapy to Prevent Strokes 2Landmark Study Finds Expensive Catheter Procedure to Close Hole in Heart No More Effective Than Medical Therapy to Prevent Strokes 3
(Date:5/28/2015)... 28, 2015 Real Time Pain Relief ... products, today announced their best-selling lotion is now available in ... Relief is an FDA registered OTC pain relief product. It ... such as Aloe Vera, Arnica, Capsicum, Chondroitin, Emu Oil, Glucosamine, ... Menthol – only 1.25% – to avoid buildup of Substance ...
(Date:5/28/2015)... The Khanna Vision Institute announced the ... to make learning about treatment of keratoconus fun. ... years. This proliferation of treatment techniques has not reached ... the nuances of the cutting edge technologies. Dr.Khanna, medical ... can be boring and printed material can be onerous ...
(Date:5/28/2015)... Optimity Advisors ( Optimity ) – ... care for healthcare organizations worldwide – today announced ... operationalize contracting and engagement models. As part of ... of seven “ OrangePapers” that provide actionable ... a strategy, operations and information technology advisory firm ...
(Date:5/28/2015)... The drug epidemic has struck the New ... on May 12th, 2015, by Bradenton , the campus ... The first victim, Dylan Besser (21) was a University of ... The second overdose victim, Julian Toomsen-Hall (18) was also pronounced ... overdose deaths on campus, the college has created a drug ...
(Date:5/28/2015)... The report “Dystonia – Pipeline Review, ... development for Dystonia. Dystonia is characterized by persistent ... movements, postures, or both. Dystonia affects men, women, ... report strengthens R&D pipelines by identifying new targets ... Complete report on H1 2015 pipeline review of ...
Breaking Medicine News(10 mins):Health News:Real Time Pain Relief Introduces New Four Ounce Pump Bottle for their Popular Pain Relief Lotion 2Health News:Dr.Khanna Announced the Release of an Interactive Web Application for Keratoconus Treatment 2Health News:Optimity Advisors Now Offers Outcomes Based Contracting Services to Support Engagement Model For New Healthcare Innovative Models of Care 2Health News:Two College Campus Deaths Force Sarasota College to Create Drug Task Force 2Health News:Two College Campus Deaths Force Sarasota College to Create Drug Task Force 3Health News:Dystonia Therapeutic Assessment Pipeline Review H1 2015 Market Research Report Available at RnRMarketResearch.com 2Health News:Dystonia Therapeutic Assessment Pipeline Review H1 2015 Market Research Report Available at RnRMarketResearch.com 3Health News:Dystonia Therapeutic Assessment Pipeline Review H1 2015 Market Research Report Available at RnRMarketResearch.com 4
... SPF 30: First Scar Product to Receive AAD ... American Academy of Dermatology (AAD) has honored Merz ... product for its sun-protection benefit. The AAD SEAL ... benefit based on review of independent testing results ...
... (May 27, 2009) Kevin Bruhn, PhD, is the winner ... honor aimed at nurturing excellence and providing support for a ... Bruhn came to LA BioMed in 2005 after receiving his ... of California, Los Angeles in 2004 and completing a postdoctoral ...
... Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT ), ... commercialization of proprietary products that address important therapeutic needs ... A. Oclassen, President & Chief Executive Officer, is scheduled ... Conference in New York City on Wednesday, June 10, ...
... Therapeutics (NYSE Amex: CXM ) and its ... entitled "Phase 2b Study of GAM501 (Ad5PDGF-B/Collagen) in the ... Clinical Trials Symposium at the American Society of Gene ... May 27, 2009. Dr. Barbara K. Sosnowski, Cardium,s ...
... Chemical-Free Cleaning Process Offers Greater than 99.9 Percent Bacterial ... Pro, a convenient hand-held device that offers a breakthrough ... powerful general-purpose cleaner, has now been certified as a ... as directed, the Activeion Pro offers a greater than ...
... May 28 Today, Express Scripts, Inc. (Nasdaq: ... under the Hart-Scott-Rodino Act in connection with its premerger ... of WellPoint, Inc.,s (NYSE: WLP ) NextRx ... This represents a significant step forward towards completion of ...
Cached Medicine News:Health News:American Academy of Dermatology Recognizes Merz Pharmaceuticals 2Health News:American Academy of Dermatology Recognizes Merz Pharmaceuticals 3Health News:American Academy of Dermatology Recognizes Merz Pharmaceuticals 4Health News:Transcept Pharmaceuticals to Present at Needham Life Sciences Conference on June 10, 2009 2Health News:Transcept Pharmaceuticals to Present at Needham Life Sciences Conference on June 10, 2009 3Health News:Cardium Presents Gene Activated Matrix Technology and Update on Excellarate Clinical Development Program at ASGT Annual Meeting 2Health News:Cardium Presents Gene Activated Matrix Technology and Update on Excellarate Clinical Development Program at ASGT Annual Meeting 3Health News:Cardium Presents Gene Activated Matrix Technology and Update on Excellarate Clinical Development Program at ASGT Annual Meeting 4Health News:Cardium Presents Gene Activated Matrix Technology and Update on Excellarate Clinical Development Program at ASGT Annual Meeting 5Health News:Cardium Presents Gene Activated Matrix Technology and Update on Excellarate Clinical Development Program at ASGT Annual Meeting 6Health News:Cardium Presents Gene Activated Matrix Technology and Update on Excellarate Clinical Development Program at ASGT Annual Meeting 7Health News:Cardium Presents Gene Activated Matrix Technology and Update on Excellarate Clinical Development Program at ASGT Annual Meeting 8Health News:Certified Lab Tests Confirm the Activeion Pro Is a Sanitizing Device 2Health News:Certified Lab Tests Confirm the Activeion Pro Is a Sanitizing Device 3Health News:Express Scripts Announces Expiration of Hart-Scott-Rodino Waiting Period for Acquisition of WellPoint's NextRx Subsidiaries 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: